Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 2,436,998 $ 343,717
General and administrative expenses 1,992,928 970,384
Total operating expenses 4,429,926 1,314,101
Loss from operations (4,429,926) (1,314,101)
Other (expense) income:    
Loss on debt conversion with related party (6,134,120)  
Interest (expense) income, net (147,090) 22,766
Exchange loss, net (23,274)  
Total other (expense) income (6,304,484) 22,766
Loss before income taxes (10,734,410) (1,291,335)
Deferred income tax expense (190,542) 0
Net loss (10,924,952) (1,291,335)
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock (1,256,662)  
Net loss attributable to common stockholders $ (12,181,614) $ (1,291,335)
Net loss per common share, basic (in dollars per share) $ (8.45) $ (1.68)
Net loss per common share, diluted (in dollars per share) $ (8.45) $ (1.68)
Weighted average number of shares outstanding - basic (in shares) 1,441,535 770,317
Weighted average number of shares outstanding - diluted (in shares) 1,441,535 770,317
Comprehensive loss    
Net loss $ (10,924,952) $ (1,291,335)
Foreign currency translation adjustment 61,156  
Comprehensive loss $ (10,863,796) $ (1,291,335)